AAPL315.34-0.88 (-0.28%) ▼|ABBV250.91+2.13 (+0.86%) ▲|ABT105.23-0.29 (-0.27%) ▼|ACN175.80-3.23 (-1.80%) ▼|ADBE254.86-2.40 (-0.93%) ▼|AMAT468.85-3.94 (-0.83%) ▼|AMD521.10+15.36 (+3.04%) ▲|AMGN391.27-1.90 (-0.48%) ▼|AMT175.43-0.30 (-0.17%) ▼|AMZN252.40-4.57 (-1.78%) ▼|AVGO364.38-4.18 (-1.13%) ▼|AXP321.80-4.30 (-1.32%) ▼|BA206.42-4.31 (-2.05%) ▼|BAC62.67+0.28 (+0.45%) ▲|BKNG173.43-6.87 (-3.81%) ▼|BLK1,072.03-23.34 (-2.13%) ▼|BMY64.41-0.28 (-0.43%) ▼|BNY162.51-0.34 (-0.21%) ▼|BRK-B506.72+0.89 (+0.18%) ▲|C137.80+1.06 (+0.78%) ▲|CAT815.56-6.92 (-0.84%) ▼|CL88.03-0.38 (-0.43%) ▼|CMCSA24.59-1.74 (-6.61%) ▼|COF210.86-3.10 (-1.45%) ▼|COP136.53+1.49 (+1.10%) ▲|COST902.60-7.58 (-0.83%) ▼|CRM244.16-4.96 (-1.99%) ▼|CSCO109.43+0.26 (+0.24%) ▲|CVS95.38-0.69 (-0.72%) ▼|CVX213.81+4.01 (+1.91%) ▲|DE677.21-3.52 (-0.52%) ▼|DHR204.85-0.38 (-0.19%) ▼|DIS104.18-0.88 (-0.84%) ▼|DUK120.43-0.81 (-0.67%) ▼|EMR150.34-1.81 (-1.19%) ▼|FDX309.19-4.94 (-1.57%) ▼|GD352.67-3.91 (-1.10%) ▼|GE325.42-9.49 (-2.83%) ▼|GEV951.04-20.27 (-2.09%) ▼|GILD145.65-0.99 (-0.68%) ▼|GM83.76-2.03 (-2.37%) ▼|GOOG328.38-7.00 (-2.09%) ▼|GOOGL330.65-7.71 (-2.28%) ▼|GS1,028.78-7.75 (-0.75%) ▼|HD310.45-3.25 (-1.04%) ▼|HON204.93-3.31 (-1.59%) ▼|IBM239.94+7.85 (+3.38%) ▲|INTC106.24+1.77 (+1.69%) ▲|INTU313.94-4.99 (-1.56%) ▼|ISRG353.24+3.08 (+0.88%) ▲|JNJ267.08-2.04 (-0.76%) ▼|JPM354.71+1.20 (+0.34%) ▲|KO87.55-0.81 (-0.92%) ▼|LIN466.65-1.73 (-0.37%) ▼|LLY1,124.21+0.30 (+0.03%) ▲|LMT524.46-11.69 (-2.18%) ▼|LOW198.60-2.20 (-1.10%) ▼|LRCX315.84-4.58 (-1.43%) ▼|MA567.50-3.39 (-0.59%) ▼|MCD253.48-2.33 (-0.91%) ▼|MDLZ62.42+0.79 (+1.28%) ▲|MDT91.89-0.50 (-0.54%) ▼|META653.69+40.21 (+6.55%) ▲|MMM164.40-3.12 (-1.86%) ▼|MO67.89-0.28 (-0.41%) ▼|MRK147.53-0.93 (-0.63%) ▼|MS215.35-0.89 (-0.41%) ▼|MSFT491.65-2.30 (-0.47%) ▼|MU1,027.77+27.51 (+2.75%) ▲|NEE82.65-1.18 (-1.41%) ▼|NFLX76.03-0.74 (-0.96%) ▼|NKE37.35-0.75 (-1.97%) ▼|NOW131.11-3.10 (-2.31%) ▼|NVDA223.67-2.06 (-0.91%) ▼|ORCL161.63-0.89 (-0.55%) ▼|PEP136.69-1.76 (-1.27%) ▼|PFE27.78-0.01 (-0.04%) ▼|PG142.64-2.94 (-2.02%) ▼|PLTR169.53-0.77 (-0.45%) ▼|PM185.71+0.98 (+0.53%) ▲|QCOM176.40+2.31 (+1.33%) ▲|RTX197.55-1.26 (-0.63%) ▼|SBUX100.04-1.97 (-1.93%) ▼|SCHW106.54-0.33 (-0.31%) ▼|SO88.34-0.65 (-0.73%) ▼|SPG204.53-5.10 (-2.43%) ▼|T25.15-0.45 (-1.76%) ▼|TMO605.69+2.67 (+0.44%) ▲|TMUS177.34-4.35 (-2.39%) ▼|TSLA367.81-0.35 (-0.10%) ▼|TXN261.59+2.67 (+1.03%) ▲|UBER71.08-2.05 (-2.80%) ▼|UNH393.06-7.78 (-1.94%) ▼|UNP284.74-3.71 (-1.29%) ▼|UPS99.22-1.26 (-1.25%) ▼|USB62.11-0.38 (-0.61%) ▼|V367.39-1.25 (-0.34%) ▼|VZ49.74-0.67 (-1.33%) ▼|WFC89.67+1.71 (+1.94%) ▲|WMT105.83-0.22 (-0.21%) ▼|XOM164.23+3.57 (+2.22%) ▲|AAPL315.34-0.88 (-0.28%) ▼|ABBV250.91+2.13 (+0.86%) ▲|ABT105.23-0.29 (-0.27%) ▼|ACN175.80-3.23 (-1.80%) ▼|ADBE254.86-2.40 (-0.93%) ▼|AMAT468.85-3.94 (-0.83%) ▼|AMD521.10+15.36 (+3.04%) ▲|AMGN391.27-1.90 (-0.48%) ▼|AMT175.43-0.30 (-0.17%) ▼|AMZN252.40-4.57 (-1.78%) ▼|AVGO364.38-4.18 (-1.13%) ▼|AXP321.80-4.30 (-1.32%) ▼|BA206.42-4.31 (-2.05%) ▼|BAC62.67+0.28 (+0.45%) ▲|BKNG173.43-6.87 (-3.81%) ▼|BLK1,072.03-23.34 (-2.13%) ▼|BMY64.41-0.28 (-0.43%) ▼|BNY162.51-0.34 (-0.21%) ▼|BRK-B506.72+0.89 (+0.18%) ▲|C137.80+1.06 (+0.78%) ▲|CAT815.56-6.92 (-0.84%) ▼|CL88.03-0.38 (-0.43%) ▼|CMCSA24.59-1.74 (-6.61%) ▼|COF210.86-3.10 (-1.45%) ▼|COP136.53+1.49 (+1.10%) ▲|COST902.60-7.58 (-0.83%) ▼|CRM244.16-4.96 (-1.99%) ▼|CSCO109.43+0.26 (+0.24%) ▲|CVS95.38-0.69 (-0.72%) ▼|CVX213.81+4.01 (+1.91%) ▲|DE677.21-3.52 (-0.52%) ▼|DHR204.85-0.38 (-0.19%) ▼|DIS104.18-0.88 (-0.84%) ▼|DUK120.43-0.81 (-0.67%) ▼|EMR150.34-1.81 (-1.19%) ▼|FDX309.19-4.94 (-1.57%) ▼|GD352.67-3.91 (-1.10%) ▼|GE325.42-9.49 (-2.83%) ▼|GEV951.04-20.27 (-2.09%) ▼|GILD145.65-0.99 (-0.68%) ▼|GM83.76-2.03 (-2.37%) ▼|GOOG328.38-7.00 (-2.09%) ▼|GOOGL330.65-7.71 (-2.28%) ▼|GS1,028.78-7.75 (-0.75%) ▼|HD310.45-3.25 (-1.04%) ▼|HON204.93-3.31 (-1.59%) ▼|IBM239.94+7.85 (+3.38%) ▲|INTC106.24+1.77 (+1.69%) ▲|INTU313.94-4.99 (-1.56%) ▼|ISRG353.24+3.08 (+0.88%) ▲|JNJ267.08-2.04 (-0.76%) ▼|JPM354.71+1.20 (+0.34%) ▲|KO87.55-0.81 (-0.92%) ▼|LIN466.65-1.73 (-0.37%) ▼|LLY1,124.21+0.30 (+0.03%) ▲|LMT524.46-11.69 (-2.18%) ▼|LOW198.60-2.20 (-1.10%) ▼|LRCX315.84-4.58 (-1.43%) ▼|MA567.50-3.39 (-0.59%) ▼|MCD253.48-2.33 (-0.91%) ▼|MDLZ62.42+0.79 (+1.28%) ▲|MDT91.89-0.50 (-0.54%) ▼|META653.69+40.21 (+6.55%) ▲|MMM164.40-3.12 (-1.86%) ▼|MO67.89-0.28 (-0.41%) ▼|MRK147.53-0.93 (-0.63%) ▼|MS215.35-0.89 (-0.41%) ▼|MSFT491.65-2.30 (-0.47%) ▼|MU1,027.77+27.51 (+2.75%) ▲|NEE82.65-1.18 (-1.41%) ▼|NFLX76.03-0.74 (-0.96%) ▼|NKE37.35-0.75 (-1.97%) ▼|NOW131.11-3.10 (-2.31%) ▼|NVDA223.67-2.06 (-0.91%) ▼|ORCL161.63-0.89 (-0.55%) ▼|PEP136.69-1.76 (-1.27%) ▼|PFE27.78-0.01 (-0.04%) ▼|PG142.64-2.94 (-2.02%) ▼|PLTR169.53-0.77 (-0.45%) ▼|PM185.71+0.98 (+0.53%) ▲|QCOM176.40+2.31 (+1.33%) ▲|RTX197.55-1.26 (-0.63%) ▼|SBUX100.04-1.97 (-1.93%) ▼|SCHW106.54-0.33 (-0.31%) ▼|SO88.34-0.65 (-0.73%) ▼|SPG204.53-5.10 (-2.43%) ▼|T25.15-0.45 (-1.76%) ▼|TMO605.69+2.67 (+0.44%) ▲|TMUS177.34-4.35 (-2.39%) ▼|TSLA367.81-0.35 (-0.10%) ▼|TXN261.59+2.67 (+1.03%) ▲|UBER71.08-2.05 (-2.80%) ▼|UNH393.06-7.78 (-1.94%) ▼|UNP284.74-3.71 (-1.29%) ▼|UPS99.22-1.26 (-1.25%) ▼|USB62.11-0.38 (-0.61%) ▼|V367.39-1.25 (-0.34%) ▼|VZ49.74-0.67 (-1.33%) ▼|WFC89.67+1.71 (+1.94%) ▲|WMT105.83-0.22 (-0.21%) ▼|XOM164.23+3.57 (+2.22%) ▲|
23.6 C
New York
Thursday, September 10, 2026

Tag: rights

newssourceFORcompanyinformationcontent1releasesmarket

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PHR

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”), of the important July 13, 2026 lead plaintiff deadline.

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Company announcement No. 21 / 2026

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 7, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 8, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VERI

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Veritone, Inc. (NASDAQ: VERI) between October 14, 2025 and April 14, 2026, inclusive (the “Class Period”), of the important July 20, 2026 lead plaintiff deadline.

Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Immutep (IMMP) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 7/6/2026

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, June 7, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit...

Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, June 7, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit...

Bronstein, Gewirtz & Grossman LLC Urges CommVault Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for CommVault (CVLT) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 7/17/2026

Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for POET Technologies Inc. urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/29/2026

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant...

BW IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Babcock & Wilcox Enterprises, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before...

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Babcock & Wilcox Enterprises, Inc. (“B&W”) (NYSE: BW) between November 5, 2025 and March 11, 2026, inclusive (the “Class Period”), of the important June 15, 2026 lead plaintiff deadline.

Bitty & Beau’s Coffee Launches New Mini Cruiser Franchise Model

Nationally recognized coffee brand introduces a lower-cost mobile franchise designed to expand inclusion, opportunity, and entrepreneurship nationwide. ...

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRights

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers